Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice

Journal of Virology

Volumn 71, Issue 8, 1997, Pages 5905-5914

  Gulliver, Gene A ^a   Herber, Renee L ^a   Liem, Amy ^a   Lambert, Paul F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; EPIDERMIS HYPERPLASIA; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE; PAPILLOMA VIRUS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS EPITHELIUM; TRANSGENIC MOUSE; UTERINE CERVIX CARCINOMA; VIRUS GENOME;

EID: 0030848170     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.8.5905-5914.1997     Document Type: Article

References (57)

1. Antinore, M. J., M. J. Birrer, D. Patel, L. Nader, and D. J. McCance. 1996. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the API family of transcription factors. EMBO J. 15:1950-1960.
2. Arbeit, J. M., K. Münger, P. M. Howley, and D. Hanahan. 1993. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs. Am. J. Pathol. 142:1187-1197.
3. Arbeit, J. M., K. Münger, P. M. Howley, and D. Hanahan. 1994. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J. Virol. 68:4358-4368.
4. Auewarakul, P., L. Gissmann, and A. Cid-Arregui. 1994. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol. Cell. Biol. 14:8250-8258.
5. Barbosa, M. S., C. Edmunds, C. Fisher, J. T. Schiller, D. R. Lowy, and K. H. Vousden. 1990. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 9:153-160.
6. Bedell, M. A., K. H. Jones, S. R. Grossman, and L. A. Laimins. 1989. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J. Virol. 63:1247-1255.
7. Chellappan, S., V. B. Kraus, B. Kroger, K. Münger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-1553.
8. Clemens, K. E., R. Brent, J. Gyuris, and K. Münger. 1995. Dimerization of the human papillomavirus E7 oncoprotein in vivo. Virology 214:289-293.
9. Davies, R. C., and K. H. Vousden. 1992. Functional analysis of human papillomavirus type 16 E7 by complementation with adenovirus E1A mutants. J. Gen. Virol. 73:2135-2139.
10. Demers, G. W., S. A. Foster, C. L. Halbert, and D. A. Galloway. 1994. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA 91:4382-4386.
11. Dyson, N., P. M. Howley, K. Münger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
12. Edmunds, C., and K. H. Vousden. 1989. A point mutational analysis of human papillomavirus type 16 E7 protein. J. Virol. 63:2650-2656.
13. Greenhalgh, D. A., X. J. Wang, J. A. Rothnagel, J. N. Eckhardt, M. I. Quintanilla, J. L. Barber, D. S. Bundman, M. A. Longley, R. Schlegel, and D. R. Roop. 1994. Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous. rasHa-activated papillomas. Cell Growth Differ. 5:667-675.
14. Griep, A. E., R. Herber, S. Jeon, J. K. Lohse, R. R. Dubielzig, and P. F. Lambert. 1993. Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J. Virol. 67:1373-1384.
15. Griep, A. E., T. Kuwabara, E. J. Lee, and H. Westphal. 1989. Perturbed development of the mouse lens by polyoma large T antigen: evidence for regulation by an endogenous growth factor. Genes Dev. 3:1075-1085.
16. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-178.
17. Herber, R., A. Liem, H. Pitot, and P. F. Lambert. 1996. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 70:1873-1881.
18. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
19. Howes, K. A., N. Ransom, D. S. Papermaster, J. G. Lasudry, D. M. Albert, and J. J. Windle. 1994. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8:1300-1310.
20. Jeon, S., and P. F. Lambert. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
21. Jewers, R. J., P. Hildebrandt, J. W. Ludlow, B. Kell, and D. J. McCance. 1992. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol. 66:1329-1335.
22. 1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71:2905-2912.
23. Kondoh, G., Y. Murata, K. Aozasa, M. Yutsudo, and A. Hakura. 1991. Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice. J. Virol. 65:3335-3339.
24. Krieg, T. M., M. P. Schafer, C. K. Cheng, D. Filpula, P. Flaherty, P. M. Steinert, and D. R. Roop. 1985. Organization of a type I keratin gene: evidence for evolution of intermediate filaments from a common ancestral gene. J. Biol. Chem. 260:5867-5870.
25. Lambert, P. F., H. Pan, H. C. Pitot, A. Liem, M. Jackson, and A. E. Griep. 1993. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA 90:5583-5587.
26. Liem, A., R. L. Herber, B. Stewart, H. P. Pitot, J. Miller, and P. F. Lambert. Human papillomavirus type 16 E6 and E7 oncogenes act synergistically with the chemical carcinogen 9,10-dimethyl-1,2-benz(a)anthracene to induce tumors in K14-HPV16E6/E7 transgenic mice. Submitted for publication.
27. Lyons, C. E., M. Ontell, R. Cox, D. Sassoon, and M. Buckingham. 1990. The expression of myosin genes in developing skeletal muscle in the mouse embryo. J. Cell Biol. 111:1465-1476.
28. Matlashewski, G., J. Schneider, L. Banks, N. Jones, A. Murray, and L. Crawford. 1987. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6:1741-1746.
29. Morozov, A., J. Subjeck, and P. Raychaudhuri. 1995. HPV16 E7 oncoprotein induces expression of a 110 kDa heat shock protein. FEBS Lett. 371:214-218.
30. Morris, G. F., and M. B. Mathews. 1989. Regulation of proliferating cell nuclear antigen during the cell cycle. J. Biol. Chem. 264:13856-13864.
31. Munger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
32. Münger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105.
33. Pan, H., and A. E. Griep. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8:1285-1299.
34. Pan, H., and A. E. Griep. 1995. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9:2157-2169.
35. Phelps, W. C., S. Bagchi, J. A. Barnes, P. Raychaudhuri, V. Kraus, K. Münger, P. M. Howley, and J. R. Nevins. 1991. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol. 65:6922-6930.
36. Phelps, W. C., K. Münger, C. L. Yee, J. A. Barnes, and P. M. Howley. 1992. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66:2418-2427.
37. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539-547.
38. Roop, D. R., C. K. Cheng, L. Titterington, C. A. Meyers, J. R. Stanley, P. M. Steinert, and S. H. Yuspa. 1984. Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J. Biol. Chem. 259:8037-8040.
39. Roop, D. R., C. K. Cheng, R. Toftgard, J. R. Stanley, P. M. Steinert, and S. H. Yuspa. 1985. The use of cDNA clones and monospecific antibodies as probes to monitor keratin gene expression. Ann. N.Y. Acad. Sci. 455:426-435.
40. Roop, D. R., T. M. Krieg, T. Mehrel, C. K. Cheng, and S. H. Yuspa. 1988. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Cancer Res. 48:3245-3252.
41. Scheffner, M., T. Takahashi, J. M. Huibregtse, J. D. Minna, and P. M. Howley. 1992. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J. Virol. 66:5100-5105.
42. Searle, P. F., D. P. Thomas, K. B. Faulkner, and J. M. Tinsley. 1994. Stomach cancer in transgenic mice expressing human papillomavirus type 16 early region genes from a keratin promoter. J. Gen. Virol. 75:1125-1137.
43. Slebos, R. J., M. H. Lee, B. S. Plunkett, T. D. Kessis, B. O. Williams, T. Jacks, L. Hedrick, M. B. Kastan, and K. R. Cho. 1994. p53-dependent G1 arrest involves pRB-related-proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91:5320-5324.
44. Song, S., and P. Lambert. Unpublished data.
45. r 67,000 provide a systematic basis for the structural and functional diversity of the end domains of keratin intermediate filament subunits. J. Biol. Chem. 260:7142-7149.
46. Storey, A., K. Osborn, and L. Crawford. 1990. Co-transformation by human papillomavirus-types 6 and 11. J. Gen. Virol. 71:165-171.
47. Storey, A., D. Pim, A. Murray, K. Osborn, L. Banks, and L. Crawford. 1988. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J. 7:1815-1820.
48. Tanaka, A., T. Noda, H. Yajima, M. Hatanaka, and Y. Ito. 1989. Identification of a transforming gene of human papillomavirus type 16. J. Virol. 63:1465-1469.
49. Vassar, R., M. Rosenberg, S. Ross, A. Tyner, and E. Fuchs. 1989. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA 86:1563-1567.
50. Vousden, K. H., J. Doniger, J. A. DiPaolo, and D. R. Lowy. 1988. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res. 3:167-175.
51. Watanabe, S., T. Kanda, H. Sato, A. Furuno, and K. Yoshiike. 1990. Mutational analysis of human papillomavirus type 16 E7 functions. J. Virol. 64:207-214.
52. Watanabe, S., and K. Yoshiike. 1988. Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA. Int. J. Cancer 41:896-900.
53. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
54. Xiong, Y., D. Kuppuswamy, Y. Li, E. M. Livanos, M. Hixon, A. White, D. Beach, and T. D. Tlsty. 1996. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J. Virol. 70:999-1008.
55. Zerfass, K., A. Schulze, D. Spitkovsky, V. Friedman, B. Henglein, and P. Jansen-Dürr. 1995. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69:6389-6399.
56. zur Hausen, H., and E. de Villier, 1994. Human papillomaviruses. Annu. Rev. Microbiol. 48:427-447.
57. Zwerschke, W., S. Joswig, and D. P. Jansen. 1996. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene 12:213-220.